Gut Microbiota and Probiotics/Synbiotics for Modulation of Immunity in Critically Ill Patients

Area of Science:

• Critical care medicine
• Immunology
• Microbiology

Background:

• Critically ill patients experience systemic inflammation due to injuries, potentially leading to organ failure.
• Gut dysfunction is a key factor in disease progression and organ failure in critical illness.
• The gut microbiota plays a crucial role in host immunity, and its disruption can lead to immunosuppression.

Purpose of the Study:

• To explore the role of probiotics and synbiotics in managing systemic inflammation in critically ill patients.
• To investigate the potential of these interventions in preventing infectious complications.

Main Methods:

• Review of existing literature on probiotics, synbiotics, and their effects in critical illness.
• Analysis of studies reporting on the modulation of gut microbiota and immune response.

Main Results:

• Probiotics and synbiotics may attenuate systemic inflammation by preserving gut microbiota integrity.
• These interventions have shown potential in reducing postoperative infections and ventilator-associated pneumonia.

Conclusions:

• Prophylactic administration of probiotics/synbiotics could be a valuable strategy for preventing infections and modulating immunity in critical care.
• Further clinical and basic research is necessary to establish intestinal therapies for critically ill patients.